Panbela Therapeutics ROCE
Cos'è ROCE di Panbela Therapeutics?
ROCE di Panbela Therapeutics Inc. è -1,359.79%
Qual è la definizione di ROCE?
Il ritorno sul capitale investito (ROCE) è un rapporto finanziario che misura la redditività di un'azienda e l'efficienza con cui viene utilizzato il suo capitale.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE di aziende nel Health Care settore su NASDAQ rispetto a Panbela Therapeutics
Cosa fa Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Aziende con roce simili a Panbela Therapeutics
- Millennial Precious Metals Corp ha ROCE di -1,485.19%
- Oragenics Inc ha ROCE di -1,468.71%
- Hemp Naturals ha ROCE di -1,452.04%
- Advantagewon Oil ha ROCE di -1,446.04%
- Paringa Resources ha ROCE di -1,393.41%
- Graycliff Exploration ha ROCE di -1,374.81%
- Panbela Therapeutics ha ROCE di -1,359.79%
- U.S. Lithium ha ROCE di -1,313.60%
- Ucommune International Ltd ha ROCE di -1,285.37%
- Kopin ha ROCE di -1,279.14%
- 22nd Century Inc ha ROCE di -1,242.47%
- Imagin Medical Inc ha ROCE di -1,230.40%
- Aravive Inc ha ROCE di -1,217.82%